In vitro diagnostic technology (IVD) has developed rapidly, ranging from gene-level gene sequencing, SNP screening, and point mutation gene diagnosis, to protein-level biomarker detection, cellular-level circulating tumor cell detection (CTC), etc. Overall, IVD companies‘ products is moving towards being simpler, faster, non-invasive, and more informative. The application prospects mainly include the following aspects:
-
Physical examination
Modern people pay more and more attention to their health, and annual physical examination has become a habit of many people. In vitro diagnosis can realize the prevention and early detection of diseases through the analysis and detection of blood, urine, feces, secretions, etc.
-
Chronic disease management
Worldwide, the incidence of diabetes, hypertension, and chronic gastric diseases is increasing year by year. There is also a high incidence of diseases such as hyperlipidemia and osteoporosis. These chronic diseases require regular monitoring of changes in blood glucose, blood pressure, blood lipids, Helicobacter pylori, and bone calcium.
-
Critical disease surveillance
After surgery and chemotherapy, many cancer patients can use in vitro diagnostic techniques to regularly monitor tumor markers to predict cancer metastasis and guide medication. For example, breast cancer patients should undergo regular chest X-rays, bone scans, liver B-ultrasounds, routine blood tests, and tumor-associated antigen tests after surgery.
Conclusion
Wondfo is an industry-leading supplier of diagnostic tests and service reagents. Wondfo specializes in precision medicine, providing tests that enable veterinarians to diagnose and treat diseases more accurately and efficiently. Due to its growing market share and expanding customer base, the company has developed strong application prospects. If you’re looking for an innovative company offering cutting-edge diagnostic tests, Wondfo should be your first choice.